Properties | Information | |
---|---|---|
PhytoCAT-ID | PhytoCAT-792 | |
Phytochemical name or plant extracts | Auraptene | |
PMID | 23434131 | |
Literature evidence | Thus, these compounds may inhibit HIF-1 activation by suppressing mitochondria-mediated hypoxic signaling. | |
IUPAC name | 7-[(2E)-3,7-dimethylocta-2,6-dienoxy]chromen-2-one | |
Phytochemicals’ class or type of plant extracts | Geranyloxycoumarin | |
Source of phytochemicals or plant Extracts | Aegle marmelos | |
Geographical availability | Assam, Bangladesh, India, Nepal, Pakistan, West Himalaya | |
Plant parts | Bark | |
Other cancers | Breast cancer | |
Target gene or protein | VEGF, VEGFR2, VCAM-1, TNFR-1, COX-2, IFNγ | |
Gene or Protein evidence | Overall, this study shows that Auraptene significantly suppressed angiogenesis via down-regulation of VEGF, VEGFR2, VCAM-1, TNFR-1, COX-2 and up-regulation of IFNγ. | |
Target pathways | HIF-1 signaling | |
IC50 | 10.2 µM against T47D (conditions - 1% O2, 16 h ) 18.8 µM against T47D (condition - 10 μM 1,10-phen, 16 h) | |
Potency | NA | |
Cell line/ mice model | T47D, 4T, MDA-MB-231, HUVEC | |
Additional information | While these findings suggest that geranyloxycoumarins potentially exert antitumor effects by inhibiting hypoxia-induced HIF-1 activation, these results also imply that these relatively common phytochemicals may have the potential to induce mitochondrial poison-associated toxicities, such as liver damage29 and neurodegeneration | |
PubChem ID | 1550607 | |
Additional PMIDs | 34851565 | |
Additional sources of information | https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:770819-1 | |
Safety | NA |